162 related articles for article (PubMed ID: 25589571)
21. Impact of Engineered Carbon Nanodiamonds on the Collapse Mechanism of Model Lung Surfactant Monolayers at the Air-Water Interface.
Chakraborty A; Hertel A; Ditmars H; Dhar P
Molecules; 2020 Feb; 25(3):. PubMed ID: 32046011
[TBL] [Abstract][Full Text] [Related]
22. Influence of hydrophobic alkylated gold nanoparticles on the phase behavior of monolayers of DPPC and clinical lung surfactant.
Tatur S; Badia A
Langmuir; 2012 Jan; 28(1):628-39. PubMed ID: 22118426
[TBL] [Abstract][Full Text] [Related]
23. Phase transitions in films of lung surfactant at the air-water interface.
Nag K; Perez-Gil J; Ruano ML; Worthman LA; Stewart J; Casals C; Keough KM
Biophys J; 1998 Jun; 74(6):2983-95. PubMed ID: 9635752
[TBL] [Abstract][Full Text] [Related]
24. Analysis of pulmonary surfactant in rat lungs after inhalation of nanomaterials: Fullerenes, nickel oxide and multi-walled carbon nanotubes.
Kadoya C; Lee BW; Ogami A; Oyabu T; Nishi K; Yamamoto M; Todoroki M; Morimoto Y; Tanaka I; Myojo T
Nanotoxicology; 2016; 10(2):194-203. PubMed ID: 25950198
[TBL] [Abstract][Full Text] [Related]
25. How does pulmonary surfactant reduce surface tension to very low values?
Zuo YY; Possmayer F
J Appl Physiol (1985); 2007 May; 102(5):1733-4. PubMed ID: 17303712
[No Abstract] [Full Text] [Related]
26. Effects of eicosane, a component of nanoparticles in diesel exhaust, on surface activity of pulmonary surfactant monolayers.
Kanno S; Furuyama A; Hirano S
Arch Toxicol; 2008 Nov; 82(11):841-50. PubMed ID: 18488198
[TBL] [Abstract][Full Text] [Related]
27. Physicochemical properties of nanoparticles regulate translocation across pulmonary surfactant monolayer and formation of lipoprotein corona.
Hu G; Jiao B; Shi X; Valle RP; Fan Q; Zuo YY
ACS Nano; 2013 Dec; 7(12):10525-33. PubMed ID: 24266809
[TBL] [Abstract][Full Text] [Related]
28. Size dependent interactions of nanoparticles with lung surfactant model systems and the significant impact on surface potential.
Ku T; Gill S; Löbenberg R; Azarmi S; Roa W; Prenner EJ
J Nanosci Nanotechnol; 2008 Jun; 8(6):2971-8. PubMed ID: 18681033
[TBL] [Abstract][Full Text] [Related]
29. Metastability of a supercompressed fluid monolayer.
Smith EC; Crane JM; Laderas TG; Hall SB
Biophys J; 2003 Nov; 85(5):3048-57. PubMed ID: 14581205
[TBL] [Abstract][Full Text] [Related]
30. Drug Meets Monolayer: Understanding the Interactions of Sterol Drugs with Models of the Lung Surfactant Monolayer Using Molecular Dynamics Simulations.
Hossain SI; Islam MZ; Saha SC; Deplazes E
Methods Mol Biol; 2022; 2402():103-121. PubMed ID: 34854039
[TBL] [Abstract][Full Text] [Related]
31. Pulmonary surfactant proteins SP-B and SP-C in spread monolayers at the air-water interface: I. Monolayers of pulmonary surfactant protein SP-B and phospholipids.
Taneva S; Keough KM
Biophys J; 1994 Apr; 66(4):1137-48. PubMed ID: 8038385
[TBL] [Abstract][Full Text] [Related]
32. Nanoparticle interaction with model lung surfactant monolayers.
Harishchandra RK; Saleem M; Galla HJ
J R Soc Interface; 2010 Feb; 7 Suppl 1(Suppl 1):S15-26. PubMed ID: 19846443
[TBL] [Abstract][Full Text] [Related]
33. Pulmonary surfactant protein SP-C causes packing rearrangements of dipalmitoylphosphatidylcholine in spread monolayers.
Pérez-Gil J; Nag K; Taneva S; Keough KM
Biophys J; 1992 Jul; 63(1):197-204. PubMed ID: 1420867
[TBL] [Abstract][Full Text] [Related]
34. Transport of nanoparticles across pulmonary surfactant monolayer: a molecular dynamics study.
Xu Y; Deng L; Ren H; Zhang X; Huang F; Yue T
Phys Chem Chem Phys; 2017 Jul; 19(27):17568-17576. PubMed ID: 28621369
[TBL] [Abstract][Full Text] [Related]
35. Cholesterol modifies the properties of surface films of dipalmitoylphosphatidylcholine plus pulmonary surfactant-associated protein B or C spread or adsorbed at the air-water interface.
Taneva S; Keough KM
Biochemistry; 1997 Jan; 36(4):912-22. PubMed ID: 9020791
[TBL] [Abstract][Full Text] [Related]
36. Computational Studies of Lipid-Wrapped Gold Nanoparticle Transport Through Model Lung Surfactant Monolayers.
Hossain SI; Gandhi NS; Hughes ZE; Saha SC
J Phys Chem B; 2021 Feb; 125(5):1392-1401. PubMed ID: 33529013
[TBL] [Abstract][Full Text] [Related]
37. Electrical surface potential of pulmonary surfactant.
Leonenko Z; Rodenstein M; Döhner J; Eng LM; Amrein M
Langmuir; 2006 Nov; 22(24):10135-9. PubMed ID: 17107011
[TBL] [Abstract][Full Text] [Related]
38. Differential effects of surfactant protein A on regional organization of phospholipid monolayers containing surfactant protein B or C.
Taneva SG; Keough KM
Biophys J; 2000 Oct; 79(4):2010-23. PubMed ID: 11023905
[TBL] [Abstract][Full Text] [Related]
39. Structural characterization of the monolayer-multilayer transition in a pulmonary surfactant model: IR studies of films transferred at continuously varying surface pressures.
Mao G; Desai J; Flach CR; Mendelsohn R
Langmuir; 2008 Mar; 24(5):2025-34. PubMed ID: 18198907
[TBL] [Abstract][Full Text] [Related]
40. Folding of lipid monolayers containing lung surfactant proteins SP-B(1-25) and SP-C studied via coarse-grained molecular dynamics simulations.
Duncan SL; Larson RG
Biochim Biophys Acta; 2010 Sep; 1798(9):1632-50. PubMed ID: 20435014
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
